Multimeric-001 250 mcg

BIOLOGICAL2 trials

Sponsors

BiondVax Pharmaceuticals ltd.

Conditions

HealthyInfluenza

Phase 1

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)

CompletedNCT00877448

BiondVax Pharmaceuticals ltd.Healthy

Start: 2009-06-30End: 2009-11-30Updated: 2023-03-07

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers

CompletedNCT01010737

BiondVax Pharmaceuticals ltd.Influenza

Start: 2009-09-30End: 2010-03-31Updated: 2012-07-31